Biohaven Ltd. (BHVN)
(Delayed Data from NYSE)
$14.71 USD
-0.39 (-2.58%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $14.72 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2025
Time: -- |
6/2025 | $-1.94 | 0.00% |
Earnings Summary
For their last quarter, Biohaven Ltd. (BHVN) reported earnings of -$2.17 per share, missing the Zacks Consensus Estimate of -$1.67 per share. This reflects a negative earnings surprise of 29.94%. Look out for BHVN's next earnings release expected on August 14, 2025. For the next earning release, we expect the company to report earnings of -$1.94 per share, reflecting a year-over-year increase of 46.7%.
Earnings History
Price & Consensus
Zacks News for BHVN
Company News for Jan 2, 2025
BHVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal
Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
BHVN Stock Up as Rare Neurological Disease Study Meets Primary Goal
BHVN FAQs
Based on past history, Zacks believes Biohaven Ltd. (BHVN) will report their next quarter earnings on August 14, 2025. For the next earning release, we expect the company to report earnings of -1.94 per share, reflecting a year-over-year increase of 46.70.
Based on past history, Zacks believes Biohaven Ltd. (BHVN) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on August 14, 2025.
The Zacks Consensus Estimate for Biohaven Ltd. (BHVN) for the quarter ending June 2025 is $-1.94 a share. We expect Biohaven Ltd. (BHVN) to report earnings in line with the consensus estimate of $-1.94 per share
In the earnings report for the quarter ending in June 2024, Biohaven Ltd. (BHVN) announced earnings of $-3.64 per share versus the Zacks Consensus Estimate of $-1.72 per share, representing a surprise of 111.63%.